EmGenisys

EmGenisys is an animal health technology company that has developed a revolutionary software solution to evaluate the viability and health of bovine embryos during in vitro fertilization (IVF) and embryo transfer procedures. The company's flagship products, EmVision, a Software-as-a-Service platform, and EmGenuity, an analytics and assessment tool, leverages machine learning and AI to analyze videos of embryos recorded through a microscope.

The technology works by having veterinarians or embryologists record 30-second videos of embryos using their smartphones mounted on a microscope. These videos are then uploaded to EmGenisys' web-based platform, where the software analyzes each frame, scanning the embryos for signs of life, growth, and development. The system can identify embryos that are non-viable, dead, or dying, allowing practitioners to select only the healthiest embryos for transfer, improving pregnancy outcomes by up to 20%.

Key customers and partnerships

In September 2022, the company partnered with Custom Surgical, another Luminate NY accelerator participant, to optimize video quality and improve the accuracy and user-friendliness of its product. 

Funding and financials

In March 2022, the company received an initial investment of USD 50,000 from the Luminate NY accelerator program. This funding helped accelerate the commercialization of its embryo evaluation technology.